{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:32:28Z","timestamp":1789050748651,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Dutch Ministry of Health"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.vaccine.2017.11.066","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T22:35:33Z","timestamp":1512167733000},"page":"220-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination"],"prefix":"10.1016","volume":"36","author":[{"given":"Saskia","family":"van der Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A.M.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy A.M.","family":"Berbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Buisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"40","key":"10.1016\/j.vaccine.2017.11.066_b0005","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1016\/j.vaccine.2009.07.010","article-title":"Pertussis before and after the introduction of acellular pertussis vaccines in Finland","volume":"27","author":"Elomaa","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2017.11.066_b0010","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/JCM.38.2.800-806.2000","article-title":"Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis","volume":"38","author":"de Melker","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.11.066_b0015","unstructured":"Global routine vaccination coverage, 2015. Wkly Epidemiol Rec 2016;91(46):537\u201343."},{"issue":"9","key":"10.1016\/j.vaccine.2017.11.066_b0020","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJMp1209051","article-title":"Epidemic pertussis in 2012\u2013the resurgence of a vaccine-preventable disease","volume":"367","author":"Cherry","year":"2012","journal-title":"N Engl J Med"},{"issue":"42","key":"10.1016\/j.vaccine.2017.11.066_b0025","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1016\/j.vaccine.2015.08.066","article-title":"The impact of parental postpartum pertussis vaccination on infection in infants: a population-based study of cocooning in Western Australia","volume":"33","author":"Carcione","year":"2015","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2017.11.066_b0030","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/infdis\/jiu001","article-title":"Changing pertussis epidemiology: everything old is new again","volume":"209","author":"Clark","year":"2014","journal-title":"J Infect Dis"},{"issue":"47","key":"10.1016\/j.vaccine.2017.11.066_b9000","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.47.17-00011","article-title":"Enhanced Bordetella pertussis acquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection","volume":"22","author":"van der Lee","year":"2017","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.vaccine.2017.11.066_b0035","doi-asserted-by":"crossref","first-page":"e20153326","DOI":"10.1542\/peds.2015-3326","article-title":"Waning Tdap effectiveness in adolescents","volume":"137","author":"Klein","year":"2016","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.vaccine.2017.11.066_b0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1473-3099(11)70007-X","article-title":"Rationale for pertussis booster vaccination throughout life in Europe","volume":"11","author":"Zepp","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2017.11.066_b0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/1942602X12452443","article-title":"CDC update on pertussis surveillance and Tdap vaccine recommendations","volume":"27","author":"Clark","year":"2012","journal-title":"NASN Sch Nurse"},{"issue":"6","key":"10.1016\/j.vaccine.2017.11.066_b0050","doi-asserted-by":"crossref","first-page":"e1716","DOI":"10.1542\/peds.2012-3836","article-title":"Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers","volume":"131","author":"Klein","year":"2013","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.vaccine.2017.11.066_b0055","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/cid\/cit046","article-title":"Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort","volume":"56","author":"Witt","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"47","key":"10.1016\/j.vaccine.2017.11.066_b0060","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1016\/j.vaccine.2009.08.052","article-title":"IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4\u202fyears of age: effect of vaccine antigen content","volume":"27","author":"Hendrikx","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2017.11.066_b0065","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1128\/CVI.00277-12","article-title":"T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-year-old Dutch children","volume":"19","author":"Schure","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"34","key":"10.1016\/j.vaccine.2017.11.066_b0070","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1016\/j.vaccine.2011.05.094","article-title":"Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4\u202fyears of age","volume":"29","author":"Hendrikx","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.066_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2013.10.056","article-title":"Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination","author":"Smits","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.11.066_b0080","first-page":"35","article-title":"Persistence of T-cell immune response induced by two acellular pertussis vaccines in children five years after primary vaccination","volume":"39","author":"Palazzo","year":"2016","journal-title":"New Microbiol"},{"issue":"43","key":"10.1016\/j.vaccine.2017.11.066_b0085","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1016\/j.vaccine.2009.07.075","article-title":"Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy","volume":"27","author":"Dirix","year":"2009","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2017.11.066_b0090","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0264-410X(98)00226-6","article-title":"A search for serologic correlates of immunity to Bordetella pertussis cough illnesses","volume":"16","author":"Cherry","year":"1998","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2017.11.066_b0095","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2017.11.066_b0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cid\/ciu821","article-title":"A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012\u20132013","volume":"60","author":"Dabrera","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"9953","key":"10.1016\/j.vaccine.2017.11.066_b0105","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet"},{"issue":"2 Suppl. 2","key":"10.1016\/j.vaccine.2017.11.066_b0110","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"40","key":"10.1016\/j.vaccine.2017.11.066_b0115","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.1016\/j.vaccine.2011.07.055","article-title":"Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children","volume":"29","author":"Hendrikx","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2017.11.066_b0120","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: an odd antibody","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.vaccine.2017.11.066_b0125","unstructured":"ECDC. Recommended immunisations for pertussis. <https:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx> [accessed 12 December 2015]; Available from: <http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx> [accessed 12 December 2015]."},{"issue":"9","key":"10.1016\/j.vaccine.2017.11.066_b0130","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1128\/CVI.00270-13","article-title":"Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2\u202fyears after preschool acellular booster vaccination","volume":"20","author":"Schure","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.11.066_b0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.vaccine.2011.10.048","article-title":"Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9\u202fyears of age","volume":"30","author":"Hendrikx","year":"2011","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2017.11.066_b0140","doi-asserted-by":"crossref","first-page":"e41928","DOI":"10.1371\/journal.pone.0041928","article-title":"Pertussis circulation has increased T-cell immunity during childhood more than a second acellular booster vaccination in Dutch children 9\u202fyears of age","volume":"7","author":"Schure","year":"2012","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2017.11.066_b0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2008.02.018","article-title":"Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus","volume":"335","author":"van Gageldonk","year":"2008","journal-title":"J Immunol Methods"},{"issue":"7","key":"10.1016\/j.vaccine.2017.11.066_b0150","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1128\/CVI.05081-11","article-title":"Improved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoid","volume":"18","author":"van Gageldonk","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2017.11.066_b0155","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1097\/INF.0000000000001620","article-title":"Elevated immune response among children 4\u202fyears of age with pronounced local adverse events after the fifth diphtheria, tetanus, acellular pertussis vaccination","volume":"36","author":"van der Lee","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.11.066_b0160","unstructured":"Galazka AM. The immunological basis for immunosation. Diphtheria. Geneva: World Health Organization; 1993. WHO\/EPI\/Gen\/9312."},{"key":"10.1016\/j.vaccine.2017.11.066_b0165","unstructured":"Galazka AM. The immunological basis for immunosation. Tetanus. Geneva: World Health Organization; 1993. WHO\/EPI\/Gen\/9313."},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2017.11.066_b0170","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/S0264-410X(02)00823-X","article-title":"Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough","volume":"21","author":"Giammanco","year":"2003","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2017.11.066_b0175","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1128\/jcm.27.7.1567-1571.1989","article-title":"Subclass compositions of immunoglobulin G to pertussis toxin in patients with whooping cough, in healthy individuals, and in recipients of a pertussis toxoid vaccine","volume":"27","author":"Zackrisson","year":"1989","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.11.066_b0180","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3349\/ymj.1989.30.2.158","article-title":"Changes of tetanus specific IgG, IgM and IgG subclasses after DPT vaccination","volume":"30","author":"Kim","year":"1989","journal-title":"Yonsei Med J"},{"issue":"4","key":"10.1016\/j.vaccine.2017.11.066_b0185","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.4049\/jimmunol.167.4.2411","article-title":"Down-regulation of IgE and IgG4 antibodies to tetanus toxoid and diphtheria toxoid by covaccination with cellular Bordetella pertussis vaccine","volume":"167","author":"Gruber","year":"2001","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2017.11.066_b0190","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1128\/CVI.00074-07","article-title":"Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice","volume":"14","author":"Geurtsen","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.11.066_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.1998.00401.x","article-title":"Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children","volume":"93","author":"Ryan","year":"1998","journal-title":"Immunology"},{"issue":"3 Pt 2","key":"10.1016\/j.vaccine.2017.11.066_b0200","first-page":"570","article-title":"Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines","volume":"96","author":"Meade","year":"1995","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2017.11.066_b0205","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11882-016-0621-x","article-title":"The developmental history of IgE and IgG4 antibodies in relation to atopy, eosinophilic esophagitis, and the modified TH2 response","volume":"16","author":"Aalberse","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2017.11.066_b0210","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1586\/14760584.2014.936391","article-title":"Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity","volume":"13","author":"Allen","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"5844","key":"10.1016\/j.vaccine.2017.11.066_b0215","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2017.11.066_b0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11882-016-0600-2","article-title":"Potential mechanisms for IgG4 inhibition of immediate hypersensitivity reactions","volume":"16","author":"James","year":"2016","journal-title":"Curr Allergy Asthma Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17316778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17316778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:24:58Z","timestamp":1759400698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17316778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0264410X17316778"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}